Literature DB >> 14612353

Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.

I Sermet-Gaudelus1, J C Souberbielle, I Azhar, J C Ruiz, P Magnine, V Colomb, C Le Bihan, D Folio, G Lenoir.   

Abstract

BACKGROUND: A major consequence of malnutrition in cystic fibrosis (CF) patients is the loss of lean body mass (LBM) and the subsequent impairment of respiratory muscle function. AIM: To determine whether insulin-like growth factor I (IGF-I) could be related to the LBM depletion and the evolution of respiratory disease in CF patients.
METHODS: LBM was evaluated by dual energy x ray absorptiometry; serum concentrations of IGF-I were measured in 24 CF patients twice with a one year interval. Both values were expressed as SD score (SDS) calculated from normal data for age, sex, and pubertal stage and analysed with respect to anthropometric evaluation and disease related conditions.
RESULTS: At the initial evaluation, IGF-I SDS had a mean value of -0.98 (range -3.6 to 3.2) and correlated with weight for age index, LBM SDS, and lung disease related conditions. Multiple regression analysis showed that only LBM remained independently related to IGF-I, suggesting that the relation of IGF-I to LBM was independent of weight and that the correlation between IGF-I and the respiratory conditions was related to the level of LBM. IGF-I SDS at the first evaluation was lower for the patients who lost > or =5% of weight for age index or > or =1 SD of LBM between the two evaluations.
CONCLUSION: Low levels of IGF-I could be crucial for clinical outcome by impairing LBM and respiratory function. IGF-I could be a tool for nutritional evaluation by identifying the CF patients at risk of LBM depletion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612353      PMCID: PMC1719365          DOI: 10.1136/adc.88.11.956

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  44 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts.

Authors:  H Benabdeslam; I Garcia; G Bellon; R Gilly; A Revol
Journal:  Am J Clin Nutr       Date:  1998-05       Impact factor: 7.045

3.  Pseudoporphyria induced by mefenamic acid.

Authors:  A H O'Hagan; A D Irvine; G E Allen; M Walsh
Journal:  Br J Dermatol       Date:  1998-12       Impact factor: 9.302

4.  Inspiratory muscle function and body composition in cystic fibrosis.

Authors:  A A Ionescu; K Chatham; C A Davies; L S Nixon; S Enright; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  1998-10       Impact factor: 21.405

Review 5.  Malnutrition in children with cystic fibrosis: the energy-balance equation.

Authors:  J J Reilly; C A Edwards; L T Weaver
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-08       Impact factor: 2.839

6.  Body composition and health-related quality of life in patients with obstructive airways disease.

Authors:  R Shoup; G Dalsky; S Warner; M Davies; M Connors; M Khan; F Khan; R ZuWallack
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

7.  Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.

Authors:  A M Taylor; A Bush; A Thomson; P J Oades; J L Marchant; C Bruce-Morgan; J Holly; L Ahmed; D B Dunger
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

8.  Serum leptin and IGF-I levels in cystic fibrosis.

Authors:  R Arumugam; A LeBlanc; D K Seilheimer; D S Hardin
Journal:  Endocr Res       Date:  1998-05       Impact factor: 1.720

9.  Hepatic production and intestinal uptake of IGF-I: response to infection.

Authors:  C H Lang; R A Frost; J Ejiofor; D B Lacy; O P McGuinness
Journal:  Am J Physiol       Date:  1998-12

10.  IGF-I and/or growth hormone preserve diaphragm fiber size with moderate malnutrition.

Authors:  M I Lewis; A T Feinberg; M Fournier
Journal:  J Appl Physiol (1985)       Date:  1998-07
View more
  15 in total

Review 1.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

2.  Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.

Authors:  C Pascucci; R V De Biase; D Savi; S Quattrucci; A M Isidori; C Lubrano; L Gnessi; A Lenzi
Journal:  J Endocrinol Invest       Date:  2017-11-02       Impact factor: 4.256

Review 3.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

4.  Dietary essential amino acids are highly anabolic in pediatric patients with cystic fibrosis.

Authors:  Mariëlle P K J Engelen; Gulnur Com; Robert R Wolfe; Nicolaas E P Deutz
Journal:  J Cyst Fibros       Date:  2013-01-26       Impact factor: 5.482

5.  Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.

Authors:  C M Gordon; E Binello; M S LeBoff; M E Wohl; C J Rosen; A A Colin
Journal:  Osteoporos Int       Date:  2006-03-16       Impact factor: 4.507

Review 6.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Alexandra L Haagensen; Ben Carter; Zbys Fedorowicz; Brian W Houston
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

7.  Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.

Authors:  Don B Sanders; Aliza Fink; Nicole Mayer-Hamblett; Michael S Schechter; Gregory S Sawicki; Margaret Rosenfeld; Patrick A Flume; Wayne J Morgan
Journal:  J Pediatr       Date:  2015-09-02       Impact factor: 4.406

Review 8.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

9.  Deficits in Bone Geometry in Growth Hormone-Deficient Prepubertal Boys Revealed by High-Resolution Peripheral Quantitative Computed Tomography.

Authors:  Tamar G Baer; Sanchita Agarwal; Shaoxuan Chen; Codruta Chiuzan; Aviva B Sopher; Rachel Tao; Abeer Hassoun; Elizabeth Shane; Ilene Fennoy; Sharon E Oberfield; Patricia M Vuguin
Journal:  Horm Res Paediatr       Date:  2020-03-30       Impact factor: 2.852

Review 10.  Endocrine therapy for growth retardation in paediatric inflammatory bowel disease.

Authors:  Mabrouka A Altowati; Richard K Russell; S Faisal Ahmed
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.